These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24807590)

  • 1. Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.
    Mondal P; Trigun SK
    Metab Brain Dis; 2014 Dec; 29(4):1007-15. PubMed ID: 24807590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
    Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
    Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
    Jamshidzadeh A; Heidari R; Abasvali M; Zarei M; Ommati MM; Abdoli N; Khodaei F; Yeganeh Y; Jafari F; Zarei A; Latifpour Z; Mardani E; Azarpira N; Asadi B; Najibi A
    Biomed Pharmacother; 2017 Feb; 86():514-520. PubMed ID: 28024286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate transporter and receptor function in disorders of ammonia metabolism.
    Butterworth RF
    Ment Retard Dev Disabil Res Rev; 2001; 7(4):276-9. PubMed ID: 11754522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis.
    de Knegt RJ; Schalm SW; van der Rijt CC; Fekkes D; Dalm E; Hekking-Weyma I
    J Hepatol; 1994 Jan; 20(1):19-26. PubMed ID: 7911135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Glutamate and Glutamine Transport in Ammonia Neurotoxicity: State of the Art and Question Marks.
    Dabrowska K; Skowronska K; Popek M; Obara-Michlewska M; Albrecht J; Zielinska M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):306-315. PubMed ID: 29256360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptors in hyperammonemia and hepatic encephalopathy.
    Llansola M; Rodrigo R; Monfort P; Montoliu C; Kosenko E; Cauli O; Piedrafita B; El Mlili N; Felipo V
    Metab Brain Dis; 2007 Dec; 22(3-4):321-35. PubMed ID: 17701332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
    Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
    Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.
    Kristiansen RG; Rose CF; Ytrebø LM
    Metab Brain Dis; 2016 Dec; 31(6):1269-1273. PubMed ID: 27339764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for oxidative/nitrosative stress in the pathogenesis of hepatic encephalopathy.
    Bemeur C; Desjardins P; Butterworth RF
    Metab Brain Dis; 2010 Mar; 25(1):3-9. PubMed ID: 20195724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
    Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
    Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Enzymatic Antioxidant Defense in Erythrocytes of Rats with Ammonia-Induced Encephalopathy: Role of NMDA Receptors.
    Kosenko EA; Alilova GA; Tikhonova LA
    Biochemistry (Mosc); 2023 Sep; 88(9):1404-1415. PubMed ID: 37770406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats.
    Lu L; Wu C; Lu BJ; Xie D; Wang Z; Bahaji Azami NL; An YT; Wang HJ; Ye G; Sun MY
    J Ethnopharmacol; 2020 Mar; 249():112301. PubMed ID: 31622746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
    Blanco Vela CI; Poo Ramírez JL
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.
    Rao KV; Norenberg MD
    Metab Brain Dis; 2001 Jun; 16(1-2):67-78. PubMed ID: 11726090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
    Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
    Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
    Felipo V
    World J Gastroenterol; 2006 Dec; 12(48):7737-43. PubMed ID: 17203513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy.
    Heidari R
    Life Sci; 2019 Feb; 218():65-80. PubMed ID: 30578865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical science workshop: targeting the gut-liver-brain axis.
    Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
    Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.